Literature DB >> 12628720

Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure.

Ole A Breithardt1, Anil M Sinha, Ehud Schwammenthal, Nadim Bidaoui, Kai U Markus, Andreas Franke, Christoph Stellbrink.   

Abstract

OBJECTIVES: We studied the acute effects of cardiac resynchronization therapy (CRT) on functional mitral regurgitation in heart failure (HF) patients with left bundle branch block (LBBB).
BACKGROUND: Both an decrease [corrected] in left ventricular (LV) closing force and mitral valve tethering have been implicated as mechanisms for functional mitral regurgitation (FMR) in dilated hearts. We hypothesized that an increase in LV closing force achieved by CRT could act to reduce FMR.
METHODS: Twenty-four HF patients with LBBB and FMR were studied after implantation of a biventricular CRT system. Acute changes in FMR severity between intrinsic conduction (OFF) and CRT were quantified according to the proximal isovelocity surface area method by measuring the effective regurgitant orifice area (EROA). Results were compared with the changes in estimated maximal rate of left ventricular systolic pressure rise (LV+dP/dt(max)) and transmitral pressure gradients (TMP), both measured by Doppler echocardiography.
RESULTS: Cardiac resynchronization therapy was associated with a significant reduction in FMR severity. Effective regurgitant orifice area decreased from 25 +/- 19 mm(2) (OFF) to 13 +/- 8 mm(2) (CRT). The change in EROA was directly related to the increase in LV+dP/dt(max) (r = -0.83, p < 0.0001). Compared with OFF, TMP increased more rapidly during CRT, and a higher maximal TMP was observed (OFF 73 +/- 24 mm Hg vs. CRT 85 +/- 26 mm Hg, p < 0.01).
CONCLUSIONS: Functional mitral regurgitation is reduced by CRT in patients with HF and LBBB. This effect is directly related to the increased closing force (LV+dP/dt(max)). The results support the hypothesis that an increase in TMP, mediated by a rise in LV+dP/dt(max) due to more coordinated LV contraction, may facilitate effective mitral valve closure.

Entities:  

Mesh:

Year:  2003        PMID: 12628720     DOI: 10.1016/s0735-1097(02)02937-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  74 in total

Review 1.  Cardiac resynchronisation therapy: when the drugs don't work.

Authors:  R A Bleasdale; M P Frenneaux
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

2.  Cardiac resynchronization therapy: the MGH experience.

Authors:  Jagmeet P Singh; Jeremy N Ruskin
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

3.  Relation between reduction in ischaemic mitral regurgitation and improvement in regional left ventricular contractility during low dose dobutamine stress echocardiography.

Authors:  Y Abe; T Imai; K Ohue; R Otsuka; R Komatsu; M Otsuka; Y Sakanoue; T Naruko; A Itoh; M Yoshiyama; K Haze; J Yoshikawa
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

Review 4.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 5.  Three-dimensional echocardiography. New possibilities in mitral valve assessment.

Authors:  Jorge Solis; Marta Sitges; Robert A Levine; Judy Hung
Journal:  Rev Esp Cardiol       Date:  2009-02       Impact factor: 4.753

6.  Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study.

Authors:  Gregory W Woo; Susan Petersen-Stejskal; James W Johnson; Jamie B Conti; Juan A Aranda; Anne B Curtis
Journal:  J Interv Card Electrophysiol       Date:  2005-03       Impact factor: 1.900

7.  Novel Heart Failure Biomarkers Predict Improvement of Mitral Regurgitation in Patients Receiving Cardiac Resynchronization Therapy-The BIOCRT Study.

Authors:  Jonathan Beaudoin; Jagmeet P Singh; Jackie Szymonifka; Qing Zhou; Robert A Levine; James L Januzzi; Quynh A Truong
Journal:  Can J Cardiol       Date:  2016-06-02       Impact factor: 5.223

Review 8.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

Review 9.  Advances in the surgical treatment of heart failure.

Authors:  Larry A Allen; G Michael Felker
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

Review 10.  Physiology of cardiac resynchronization.

Authors:  Usha Tedrow; Michael O Sweeney; William G Stevenson
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.